Mouse Sperm Breakthrough Could Help Cure Infertility
In a tale of mice and men, Ben-Gurion University of the Negev researchers have made a breakthrough in rodents that could eventually help infertile male humans. The group, led by professor Mahmoud Huleihel, has produced mouse sperm from germ cells using in-vitro techniques.
The researchers at Shraga Segal Department of Microbiology and Immunology in the Faculty of Health Sciences in Beersheba, in cooperation with professor Eitan Lunenfeld at Soroka University Medical Center and professor Stefan Schlatt of the University of Münster in Germany, pioneered a three-dimensional cell culture system on a bed of agar to produce sperm from the germ cells. The Jerusalem Post reports that Huleihel believes that the three-dimensional cell culture system succeeded where previously-tried two-dimensional systems did not, because it uses soft agar that closely replicates the natural environment in the male mouse’s testes where the final stages of spermatogenesis normally take place.
While it is too soon to move into human experimentation with this technique, the researchers are hopeful that their discovery will eventually lead to treatments to help infertile men, or boys who risk infertility by having to undergo medical treatments that could damage their ability to produce healthy sperm later in life.
A message from our CEO & publisher Rachel Fishman Feddersen
I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.
If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.
Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism.
— Rachel Fishman Feddersen, Publisher and CEO
